Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pearson

Showing results (1081-1090 of 1,239) with videos related to

Pageof 124
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup StudyL S Lashford, P Thiesse, A Jouvet, et al.
Pediatric Blood & Cancer|July 22, 2014
Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group projectHolly J Meany, Wendy B London, Peter F Ambros, et al.
Plos One|August 2, 2014
Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastomaNada M S Al-Saffar, Lynley V Marshall, L Elizabeth Jackson, et al.
Annals of Allergy|September 1, 1981
HLA-B8 in sarcoidosisS A Olenchock, E R Heise, J J Marx, et al.
Nature Reviews. Clinical Oncology|May 17, 2017
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspectiveLucas Moreno, Andrew D J Pearson, Xavier Paoletti, et al.
Cancer Research|September 18, 2002
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastomaPenny E Lovat, Serafina Oliverio, Marco Ranalli, et al.
The Canadian Journal of Cardiology|January 16, 2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and managementGeorge Thanassoulis, Sonia Anand, Benoit J Arsenault, et al.
Rapid Communications in Mass Spectrometry : RCM|August 2, 2020
Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasmaMostafa J Khan, Simona G Codreanu, Sandeep Goyal, et al.
Frontiers in Endocrinology|January 3, 2022
Lack of Offspring Nrf2 Does Not Exacerbate the Detrimental Metabolic Outcomes Caused by <i>In Utero</i> PCB126 ExposureBrittany B Rice, Sara Y Ngo Tenlep, Obadah Tolaymat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of ageDenah R Taggart, Wendy B London, Mary Lou Schmidt, et al.
Pageof 124

Showing results (1081-1090 of 1,239) with videos related to

Sort By:
Pageof 124
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup StudyL S Lashford, P Thiesse, A Jouvet, et al.
Pediatric Blood & Cancer|July 22, 2014
Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group projectHolly J Meany, Wendy B London, Peter F Ambros, et al.
Plos One|August 2, 2014
Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastomaNada M S Al-Saffar, Lynley V Marshall, L Elizabeth Jackson, et al.
Annals of Allergy|September 1, 1981
HLA-B8 in sarcoidosisS A Olenchock, E R Heise, J J Marx, et al.
Nature Reviews. Clinical Oncology|May 17, 2017
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspectiveLucas Moreno, Andrew D J Pearson, Xavier Paoletti, et al.
Cancer Research|September 18, 2002
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastomaPenny E Lovat, Serafina Oliverio, Marco Ranalli, et al.
The Canadian Journal of Cardiology|January 16, 2026
Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and managementGeorge Thanassoulis, Sonia Anand, Benoit J Arsenault, et al.
Rapid Communications in Mass Spectrometry : RCM|August 2, 2020
Evaluating a targeted multiple reaction monitoring approach to global untargeted lipidomic analyses of human plasmaMostafa J Khan, Simona G Codreanu, Sandeep Goyal, et al.
Frontiers in Endocrinology|January 3, 2022
Lack of Offspring Nrf2 Does Not Exacerbate the Detrimental Metabolic Outcomes Caused by <i>In Utero</i> PCB126 ExposureBrittany B Rice, Sara Y Ngo Tenlep, Obadah Tolaymat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 5, 2011
Prognostic value of the stage 4S metastatic pattern and tumor biology in patients with metastatic neuroblastoma diagnosed between birth and 18 months of ageDenah R Taggart, Wendy B London, Mary Lou Schmidt, et al.
Pageof 124